RetinalGenix Technologies (RTGN) Payables (2020 - 2026)

RetinalGenix Technologies has disclosed Payables across 7 years of filings, most recently posting $1.2 million for Q1 2026.

• Payables for Q1 2026 came in at $1.2 million, up 34.13% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 34.13% YoY), and the FY2025 annual result was $1.1 million, up 22.96% from the prior year.
• Payables came in at $1.2 million for Q1 2026 at RetinalGenix Technologies, up from $1.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $1.2 million in Q1 2026 to a low of $262467.0 in Q1 2022.
• The 5-year median for Payables is $862453.0 (2024), against an average of $784909.0.
• Across the five-year window, Payables surged 141.62% in 2023 and increased 4.2% in 2024, its largest moves.
• RetinalGenix Technologies' Payables stood at $524480.0 in 2022, then surged by 68.72% to $884920.0 in 2023, then grew by 4.2% to $922083.0 in 2024, then rose by 22.96% to $1.1 million in 2025, then increased by 9.24% to $1.2 million in 2026.
• The last three Payables figures came in at $1.2 million (Q1 2026), $1.1 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.